Journals / Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi / 2004 / Cilt: 18 - Sayı: 2

Stroke subtypes and other risk factors in ischemic stroke patients with atrial fibrillation

Atrial fibrilasyonlu iskemik inme hastalarında inme alt tipleri ve diğer risk faktörleri

Pages
133–139
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Determination of potential etiology, other risk factors, and stroke subtype is necessary in these cases since decision of anticoagulation therapy and adjustment of warfarin doses may be affected by this heterogenous condition.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In ischemic stroke patients with atrial fibrillation, anticoagulation therapy is widely used in clinical practice since cardioembolism is thought to be the cause.
📊
Key Findings & Data:Data from the outpatient stroke clinic of 1509 patients has been used and other risk factors.
💡
Conclusion & Impact:Determination of potential etiology, other risk factors, and stroke subtype is necessary in these cases since decision of anticoagulation therapy and adjustment of warfarin doses may be affected by this heterogenous condition.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antikoagülanlar · Atriyal fibrilasyon · Risk faktörleri

Abstract

Objective: In ischemic stroke patients with atrial fibrillation, anticoagulation therapy is widely used in clinical practice since cardioembolism is thought to be the cause. However, cardioembolism may not be the cause in every case. Other risk factors and potential mechanisms of stroke may also be considered. Material and method: This study has evaluated stroke subtypes in ischemic stroke patients with atrial fibrillation and the relation with other risk factors. Data from the outpatient stroke clinic of 1509 patients has been used and other risk factors. Results: There were 118 cases (9.52%) with atrial fibrillation among ischemic stroke patients. Stroke subtype was mainly cardioembolism in atrial fibrillation group (61%). Other categories were atherothrombotic stroke (17%), small vessel occlusion (12%), and unidentified group (10%) respectively. Conclusion: Cardioembolism is not die only mechanism of ischemic stroke in patients with atrial fibrillation. Determination of potential etiology, other risk factors, and stroke subtype is necessary in these cases since decision of anticoagulation therapy and adjustment of warfarin doses may be affected by this heterogenous condition.

Özet

Amaç: İskemik inmeli hastalarda atrial fibrilasyonun varlığı halinde genellikle inmenin kardioembolik tipte olduğu düşünülür. Bu hastalara klinik pratikte yaygın olarak antikoagulan tedavi başlanır. Ancak bazı durumlarda, atrial fibrilasyonlu hastalarda görülen iskemik inmelerin kardioembolizme bağlı olduğu kesin olarak ortaya konamaz. Diğer risk faktörlerinin ve başka potansiyel inme mekanizmalarının da iyi değerlendirilmeleri gerekir. Gereç ve Yöntem: Bu çalışmada, serebrovasküler hastalıklar polikliniğimizin inme veri tabanına kayıtlı olan 1509 hasta içinde atrial fıbrilasyonu olanların inme alt tipleri ve diğer risk faktörleri ile olan ilişkileri incelenmiştir. Bulgular: İskemik inme grubundaki hastaların 118'inde (%9,52) atrial fibrilasyon saptandı. Atrial fibrilasyonlu hastalar arasında en. sık görülen inme alt tipinin kardiyoembolik inme (%61) olduğu belirlendi ve bunu sırasıyla aterotrombotik inme (%17), küçük damar hastalığı (%12) ve değerlendirilemeyen grup (%10) izledi. Sonuç: Atrial fibrilasyonlu iskemik inme hastalarında tek mekanizma kardioembolizm değildir. Potansiyel etyolojiııin, diğer risk faktörlerinin ve inme alt tipinin de bu olgularda iyi belirlenmesi gerekir. Antikoagulan tedavi kararında ve warfarin dozunun ayarlanmasında bu heterojen durum etkili olabilir.

🔖

Cite This Article

ŞENGÜN, İ. Ş., KUTLUK, K., ERGÖR, G. (2004). Stroke subtypes and other risk factors in ischemic stroke patients with atrial fibrillation. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, Cilt: 18 - Sayı: 2, 133–139. https://ajindex.com/articles/207545

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Penado S, Cano M, Acha O, Hernandez JL, Riancho JA. Atrial fibrillation as a risk factor for stroke recurrence. Am J Med 2003;114:206-210
  2. Evans A, Perez I, Yu G, Karla L. Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation? Stroke 2001; 32:2828-2832
  3. Bogousslavsky J, van Mele G, Regli F, Kappenberger L. Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation: The Lausanne Stroke Registry. Neurology 1990; 40: 1046-1050
  4. Caplan LR. Brain embolism, revisited. Neurology 1993; 43:1281-1287
  5. Arboix A, Garcia-Eroles L, Massons JB, Oliveres M, Pujades R, Targa C. Atrial fibrillation of cardioembolic versus atherothrombotic infarction. Intern J Cardiol 2000; 73:33-42
  6. Adams HP Jr, Bendixen BH, Kappelle J et al. III, and TOAST Investigators. Stroke 1993; 24: 35-41
  7. Wolf PA, Dawber TR, Thomas HE, Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978; 28:973-977
  8. Evans A, Perez I, Yu G, Karla L. Secondary stroke prevention in atrial fibrillation: lessons from clinical practice. Stroke 2000; 32: 2106-2111
  9. Hart RG, Pearce LA, Miller VT et al. For the SPAF Investigators. Cardioembolik vs noncardioembolik strokes in atrial fibrillation: frequency and effect of antithrombotik agents in the Stroke Prevention in Atrial Fibrillation Studies. Cerebrovasc Dis 2000; 10:39-43
  10. Caplan LR. Multiple potential risks for stroke. JAMA 2000; 283: 1479-1480
  11. Rockson SG, Albers GW. Comparing the Guidelines: Anticoagulation Therapy to Optize Stroke Prevention in Patients with Atrial Fibrillation. JACC 2004; 43: 929- 935
  12. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting strokes: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285:2844-2870
  13. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 2001; 119:194-206
  14. Modrego PJ, Pina MA, Lerin FJ. The impact of ageing on stroke subtypes, length of stay and mortality: study in the province of Teruel, Spain. Acta Neurol Scand 2003; 108:435-442
  15. Desbiens NA. Deciding on anticoagulating the oldest old with atrial fibrillation: Insights from cost-effectiveness analysis. J Am Geriatr Soc 2002; 50: 863-869
  16. Hart RG, Pearce LA, McBride R, Rothbart RM, As